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Abstract 
A placebo controlled randomized double blind study was designed to assess the suitability of oral
Midazolam as a premedication in day care surgery in adult Pakistani patients. Fifty ASA I and H
patients aged between 20-60 years received either Midazolam 7.5 mg or a placebo approximately one
hour prior to surgery. Midazolam 7.5 mg produced significant anxiolysis and sedation (p<0.001) in
comparison to placebo after one hour of premedication. There was a significant difference (p<0.001) in
the mean heart rate and blood pressure in both groups after 1 hour of premedication with a lesser rise in
blood pressure and heart rate in the Midazolam group. Psychomotor performance assessed by ‘n’
deletion test was impaired by Midazolam (p<0.001) and recall of pictures revealed differences (p<0.05)
in the groups at one hour after premedication. However, at four hours after surgery there were no
differences in both groups. These findings indicate that rapidly acting oral Midazolam in doses of 7.5
mg provided safe and effective premedication in terms of anxiolysis, sedation, amnesia and
psychomotor performance and is suitable for day surgery (JPMA 45:239,1995).
Introduction 
Many surgical procedures are now performed on a day stay basis and it is common anaesthetic practice
to avoid premedication in these patients, in the belief that recovery is prolonged. However, a high level
of anxiety is encountered at the time o induction, suggesting a need for an oral premedicant drug with
rapid onset and short duration of action. Among the clinically available benzodiazepines, Midazolam
possesses the shortest elimination half life, a feature which makes it potentially useful for short acting
day case anxiolysis. Oral Midazolam also provides rapid sedation and amnesia when administered to
adults in day care surgery in western countries. This trial was designed to test the suitability of oral
Midazolam, as a premedication for day care surgery in Pakistani patients.
Patients and Methods 
The study was approved by the Human Ethics Committee of the Aga Khan University Hospital and
informed patient consent was obtained. Fifty ASA I(nb organic, psychologic or psychiatric disturbance
with a localised pathological lesion) and II (mid to moderate systemic disturbance) patients aged
between 20 to 60 years, scheduled for day care surgery were randomly allocated to receive either
Midazolam 7.5 mg or a placebo approximately one hour prior to surgery. All patients were proxy
generated for 3 minutes prior to induction of anaesthesia. Induction was with intravenous thiopentone 4
mg/kg given over 15 seconds and anaesthesia was maintained on a mask and Magills circuit with 33%
02, 66% nitrous oxide and 2 to 3% enflurane. Data was recorded before giving premedication, one hour
after premedication i.e., before the start of surgery and at one and four hours after surgery. At each
time, the systolic and diastolic blood pressure, heart rate, respiratory rate, anxiety score1, sedation
score2, amnesia score, performance at letter deletion test and any side effects were noted. Patients were
rated on a scale of 0 (calm) to 3 (very anxious) for anxiety and on a scale of 0 (wide awake) to 5
(unarousable) for sedation. Amnesia was tested by picture card test3 in which the subject was shown a
card with nine objects on it and was asked to memorize them. After 30 minutes distraction, the number
of objects correctly recalled were scored. The subject recalled these pictures at each scoring.
Psychomotor performance test4 comprised of 25 lines of randomly typed letters. The subject was asked
to delete as many letters "n" in a 2 minutes interval. The test score was taken as the number of lines
completed minus the number of errors. The study was done in a double blind manner. The anaesthetist
involved in recording observations was unaware of the patient grouping. All results were statistically
analyzed using” Chi square test” and "Z test”.
Results 
Table shows the demographic data. There was no significant difference in the age, sex and weight of
the two groups.
Anxiolysis
The change in anxiety levels from the preoperative values is shown in Figure 1 (A-D).
Assessment at 1 hour after premedication showed significant decrease in anxiety level in the
Midazolam group compared with the placebo group (p<0.001).
Sedation
After premedication Midazolam group was moderately sedated compared to the placebo group,
(p<0.001) {Figure 2 (A-D)}.
In the Midazolam group five patients at one hour after premedication and four patients at one hour after
surgery were only rousable after being shaken. However, at four hours after surgery almost all patients
in both groups were awake.
Amnesia
Recall of pictures revealed significant differences (p<0.05) in the amnesic effects of Midazolam at one
hour after premedication compared to the placebo (Figure 3).
Psychomotor performance
The psychomotor performance after one hour of premedication was impaired in the Midazolam group
(p<0.001). The reduced scores were seen after one hour of surgery in both groups but the psychomotor
performance in the Midazolam group was significantly impaired. After four hours of surgery the mean
values were almost similar to the base line values in both groups (Figure 4).
Cardiovascular data
There was an increase in the mean heart rate before induction (p<0.001) which decreased in both
groups at one hour after surgery, although it was lower in the Midazolam group (not significant). The
difference in mean systolic and diastolic blood pressure was significant at one hour after preniedication
(p<0.0O1) (Figures 5 and 6).

Respiratory rate
There was no difference in the respiratory rate measured after premedication and after surgery.
Side effects
Five patients in the Midazolam group and three in the placebo group suffered from vomiting in the
post-operative period.
Discussion 
With the rising cost of medical care, day care surgery is gaining popularity in Pakistan. Midazolam was
first introduced in Pakistan in 1991. Its rapid onset of action and short half-life has proven useful as a
premedication in the day care surgery in Caucasian patients5. Other desirable features are anxiolysis,
sedation, amnesia and haemodynamic stability. Our results show a significant decrease in the anxiety
level and a higher number of sedated patients in the Midazolam group compared to the placebo.
Amnesic effect of Midazolam prevented anxiety. Some patients in the placebo group also showed
sedation and anxiolysis. This effect was attributed to the repeated visits of the observer which could
have been reassuring to the patients. Excessive sedation and impaired psychomotor performance seen
in 20% of the Midazolam patients is an undesirable effect. In hospitals where beds are available for
patients undergoing day surgery and stretchers for transportation, excess sedation is not a problem, but
in centers where patients walk in and out, this effect can be troublesome. The results of the study are
comparable with those of other workers2,6. Raybould et al2 compared 7.5mg and 15mg of Midazolam
with a placebo and found 7.5mg dosage to be an effective anxiolytic whereas 15mg produced
prolonged sedation and recovery period thus being undesirable in day care patients. Peach et al6
showed that Midazolam up to 10mg significantly increased sedation and provided anxiolysis without
resulting in clinically evident prolonged recovery. In conclusion, we found Midazolam a promising day
care premedicant and 7.5mg of oral Midazolam given one hour before surgery was associated with
preoperative anxiolysis, sedation and amnesia without affecting the quality of recovery or the discharge
time after ambulatory surgery and with no significant untoward effects.
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